Literature DB >> 25048010

Environmental triggers for IBD.

Aoibhlinn O'Toole1, Joshua Korzenik.   

Abstract

The fundamental elucidation of how environmental influences provoke the initiation of disease as well as flares of inflammatory bowel disease (IBD) remains incomplete. The current understanding of these diseases suggests that ulcerative colitis (UC) and Crohn's disease (CD) result from poorly defined interactions between genetic and environmental factors which culminate in the pathologic effects and clinical manifestations of these diseases. The genetic variant appears not sufficient itself to lead to the development of the clinical disease, but likely must combine with the environmental factors. The intestinal microbiome is pivotal to IBD development. A greater understanding of the contribution of these factors to dysbiosis is critical, and we aspire to restoring a healthy microbiome to treat flares and ideally prevent the development of IBD and its complications. This article aims to place the environmental influences in the context of their potential contribution to the development of the pathophysiology of IBD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25048010     DOI: 10.1007/s11894-014-0396-y

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  75 in total

1.  Diet, gut microbiota and immune responses.

Authors:  Kendle M Maslowski; Charles R Mackay
Journal:  Nat Immunol       Date:  2011-01       Impact factor: 25.606

2.  Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe--an ECCO-EpiCom study.

Authors:  J Burisch; N Pedersen; S Cukovic-Cavka; N Turk; I Kaimakliotis; D Duricova; M Bortlik; O Shonová; I Vind; S Avnstrøm; N Thorsgaard; S Krabbe; V Andersen; J F Dahlerup; J Kjeldsen; R Salupere; J Olsen; K R Nielsen; P Manninen; P Collin; K H Katsanos; E V Tsianos; K Ladefoged; L Lakatos; G Ragnarsson; E Björnsson; Y Bailey; C O'Morain; D Schwartz; S Odes; M Giannotta; G Girardin; G Kiudelis; L Kupcinskas; S Turcan; L Barros; F Magro; D Lazar; A Goldis; I Nikulina; E Belousova; D Martinez-Ares; V Hernandez; S Almer; Y Zhulina; J Halfvarson; N Arebi; H H Tsai; S Sebastian; P L Lakatos; E Langholz; P Munkholm
Journal:  J Crohns Colitis       Date:  2013-12-07       Impact factor: 9.071

3.  Exposome informatics: considerations for the design of future biomedical research information systems.

Authors:  Fernando Martin Sanchez; Kathleen Gray; Riccardo Bellazzi; Guillermo Lopez-Campos
Journal:  J Am Med Inform Assoc       Date:  2013-11-01       Impact factor: 4.497

4.  Role of genetic and environmental factors in British twins with inflammatory bowel disease.

Authors:  Siew C Ng; Susannah Woodrow; Nisha Patel; Javaid Subhani; Marcus Harbord
Journal:  Inflamm Bowel Dis       Date:  2011-05-06       Impact factor: 5.325

5.  Cesarean section and offspring's risk of inflammatory bowel disease: a national cohort study.

Authors:  Peter Bager; Jacob Simonsen; Nete Munk Nielsen; Morten Frisch
Journal:  Inflamm Bowel Dis       Date:  2011-07-07       Impact factor: 5.325

6.  Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns.

Authors:  Maria G Dominguez-Bello; Elizabeth K Costello; Monica Contreras; Magda Magris; Glida Hidalgo; Noah Fierer; Rob Knight
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

7.  Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination.

Authors:  Francis A Ennis; John Cruz; Walter E Demkowicz; Alan L Rothman; David J McClain
Journal:  J Infect Dis       Date:  2002-05-17       Impact factor: 5.226

8.  Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study.

Authors:  T Gilat; D Hacohen; P Lilos; M J Langman
Journal:  Scand J Gastroenterol       Date:  1987-10       Impact factor: 2.423

Review 9.  Review article: cellular and molecular mechanisms of NSAID-induced peptic ulcers.

Authors:  C Musumba; D M Pritchard; M Pirmohamed
Journal:  Aliment Pharmacol Ther       Date:  2009-07-03       Impact factor: 8.171

10.  CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease.

Authors:  Nicolas Barnich; Frédéric A Carvalho; Anne-Lise Glasser; Claude Darcha; Peter Jantscheff; Matthieu Allez; Harald Peeters; Gilles Bommelaer; Pierre Desreumaux; Jean-Frédéric Colombel; Arlette Darfeuille-Michaud
Journal:  J Clin Invest       Date:  2007-05-24       Impact factor: 14.808

View more
  10 in total

Review 1.  Pathway-based approaches to the treatment of inflammatory bowel disease.

Authors:  Giorgos Bamias; Theresa T Pizarro; Fabio Cominelli
Journal:  Transl Res       Date:  2015-09-07       Impact factor: 7.012

2.  Serum Proteome Profiles in Stricturing Crohn's Disease: A Pilot Study.

Authors:  Peter Townsend; Qibin Zhang; Jason Shapiro; Bobbie-Jo Webb-Robertson; Lisa Bramer; Athena A Schepmoes; Karl K Weitz; Meaghan Mallette; Heather Moniz; Renee Bright; Marjorie Merrick; Samir A Shah; Bruce E Sands; Neal Leleiko
Journal:  Inflamm Bowel Dis       Date:  2015-08       Impact factor: 5.325

3.  Role of Toll-Like Receptor 5 in the Development of Ulcerative Colitis.

Authors:  A Falah Alshimerry; R Ghalib Farhood; H Hasan Shakir
Journal:  Arch Razi Inst       Date:  2021-12-30

Review 4.  Mechanisms Underlying Dysregulation of Electrolyte Absorption in Inflammatory Bowel Disease-Associated Diarrhea.

Authors:  Shubha Priyamvada; Rochelle Gomes; Ravinder K Gill; Seema Saksena; Waddah A Alrefai; Pradeep K Dudeja
Journal:  Inflamm Bowel Dis       Date:  2015-12       Impact factor: 5.325

Review 5.  Toll-like Receptors and Inflammatory Bowel Disease.

Authors:  Yue Lu; Xinrui Li; Shanshan Liu; Yifan Zhang; Dekai Zhang
Journal:  Front Immunol       Date:  2018-01-30       Impact factor: 7.561

6.  The PSMP-CCR2 interactions trigger monocyte/macrophage-dependent colitis.

Authors:  Xiaolei Pei; Danfeng Zheng; Shaoping She; Jing Ma; Changyuan Guo; Xiaoning Mo; Yingmei Zhang; Quansheng Song; Yu Zhang; Dalong Ma; Ying Wang
Journal:  Sci Rep       Date:  2017-07-11       Impact factor: 4.379

7.  A study protocol for a randomized controlled trial of an anti-inflammatory nutritional intervention in patients with fibromyalgia.

Authors:  Ana Rita Silva; Alexandra Bernardo; Maria Fernanda de Mesquita; José Vaz Patto; Pedro Moreira; Maria Leonor Silva; Patrícia Padrão
Journal:  Trials       Date:  2021-03-09       Impact factor: 2.279

Review 8.  NF-κB signaling in inflammation and cancer.

Authors:  Tao Zhang; Chao Ma; Zhiqiang Zhang; Huiyuan Zhang; Hongbo Hu
Journal:  MedComm (2020)       Date:  2021-12-16

9.  The impact of selected food additives on the gastrointestinal tract in the example of nonspecific inflammatory bowel diseases.

Authors:  Sara Jarmakiewicz-Czaja; Dominika Piątek; Rafał Filip
Journal:  Arch Med Sci       Date:  2021-01-08       Impact factor: 3.707

10.  Habitual dietary intake of IBD patients differs from population controls: a case-control study.

Authors:  Gerard Dijkstra; Marjo J E Campmans-Kuijpers; Vera Peters; Ettje F Tigchelaar-Feenstra; Floris Imhann; Jackie A M Dekens; Morris A Swertz; Lude H Franke; Cisca Wijmenga; Rinse K Weersma; Behrooz Z Alizadeh
Journal:  Eur J Nutr       Date:  2020-04-24       Impact factor: 5.614

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.